Paul Tudor Jones Says 2027 May Be a "Very Difficult" Year for the Stock Market
CNBC
55m ago
Ai Focus
Legendarary hedge fund manager Paul Tudor Jones told CNBC that due to the increased stock supply brought about by large technology companies IPO, 2027 could be a "very, very difficult" year for the stock market. He also stated that the current negative supply environment facing the U.S. stock market might be the worst since 2002.
Helpful
No.Help

Legendary hedge fund manager Paul Tudor Jones stated to CNBC that due to the impending arrival of large tech companies IPO, the stock market may face challenges next year.

"2027 will be a very, very difficult year for the stock market," Jones said on Tuesday during the program "Squawk Box" on CNBC. "You are likely to see the most negative capital flow environment for the U.S. stock market since 2002."

The founder and chief investment officer of Tudor Investment, Jones, stated that during the bull market over the past four years, corporate repurchases and mergers and acquisitions have provided support for the stock market for most of the time, as these factors reduced the supply of stocks. However, this situation is now changing: companies in the field of artificial intelligence such as Anthropic and OpenAI are about to conduct large-scale offerings, and SpaceX has also just completed an offering. Jones also mentioned that in order to raise funds for AI, more companies may also undertake secondary offerings.

This bull market has entered its fourth year, driven by the transformative potential of artificial intelligence, with the S&P 500 index more than doubling in value during this period. However, investors are concerned that as inflation rises, bond yields increase, and the Federal Reserve takes a more hawkish stance, this bull market may begin to lose momentum.

In May of this year, this billionaire investor stated that he had purchased more stocks related to the development of AI, while also observing similarities to the early days of technological prosperity. However, he also compared the current market period to 1999, which was about a year before the burst of the internet bubble in 2000.

“I’ll be short-selling for a whole year. Really—there’s almost no value at all,” said Jones. “In 1998 and 1999, you saw so many new issues, so many IPO, and actually the same was true in 2000, 2001, and 2002 as well. Those years were the easiest to be short-selling because you kept seeing these new offerings, continuously adding supply to the market.”

Tip
$0
Like
0
Save
0
Views 16
WalletJYS reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
RBC Capital downgrades Sika AG to a 'Hold' rating
According to TipRanks, Dyson ranks 9,525th among 12,453 analysts. The current market consensus rating for Sika AG is 'moderate buy', with an average target price of 204.78 Swiss francs, representing a potential upside of 17.83% from the current level. Morgan Stanley also maintained a 'hold' rating for the stock in its report released on October 6th, with a target price of 187.00 Swiss francs.
Businessinsider
·2026-10-13 22:24:38
2
FTC and seven states accuse Martin Shkreli of violating a lifetime ban in the pharmaceutical industry and seek to prosecute him for contempt of court
The U.S. Federal Trade Commission ( FTC ) and seven states requested on Tuesday that a federal judge determine that Martin Shkreli, known as the "bad boy of the pharmaceutical industry," had contempted the court, alleging that he had "repeatedly and blatantly violated" a 2022 civil court order that barred him for life from entering the pharmaceutical industry. FTC and the states stated that since his release from prison in May 2022, Shkreli has publicly traded at least 60 pharmaceutical industry stocks and has made public comments about the business and management of several pharmaceutical companies.
CNBC
·2026-10-13 22:24:36
1
Why Has Bitcoin's Latest Rebound Stopped Around $84,000?
On October 13, Bitcoin briefly rebounded to around $84,000, but weak demand for spot Bitcoin in the United States and a dense of sell orders around that price level limited further gains. At the same time, a sharp decline in the South Korean stock market, as well as the prospects for U.S. inflation data and Federal Reserve interest rate decisions, also kept the market cautious.
crypto.news
·2026-10-13 22:24:33
2
Arizona region MLS brokers can access HouseCanary's Google property listing program
HouseCanary indicates that it has signed a data agreement with Arizona Regional MLS, which serves most areas of Arizona and has over 38,000 subscribed users. According to this agreement, the properties for sale offered by ARMLS brokerage companies that choose to join will be eligible to appear in the search results on Google.
PR Newswire
·2026-10-13 22:24:32
2
Goldman Sachs and JPMorgan Chase refuse to underwrite $3.7 billion in AI chip loans, Volta financing costs rise above 11%
According to Bloomberg, PitchBook LCD and IFR, JPMorgan Chase and Goldman Sachs jointly led a financing of approximately $5 billion for Volta Infrastructure Holdings. However, they only provided underwriting guarantees for loans related to the $1.3 billion lease portion, while adopting a "best efforts" approach for the $3.7 billion GPU loans. The yield on this transaction upon maturity ranges from 11.21% to 11.75%, which is higher than that of some similar GPU financings. This reflects that banks are still involved in AI infrastructure financing, but they have become more cautious regarding the risks associated with chip loans.
Wallstreetcn
·2026-10-13 22:24:30
4
View More